Explore the words cloud of the E-Rare-3 project. It provides you a very rough idea of what is the project "E-Rare-3" about.
The following table provides information about the project.
AGENCE NATIONALE DE LA RECHERCHE
|Coordinator Country||France [FR]|
|Total cost||23˙290˙000 €|
|EC max contribution||5˙884˙310 € (25%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2014-12-01 to 2020-11-30|
Take a look of project's partnership.
|1||AGENCE NATIONALE DE LA RECHERCHE||FR (PARIS)||coordinator||710˙253.00|
|2||BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG||DE (BONN)||participant||1˙035˙870.00|
|3||ZORGONDERZOEK NEDERLAND ZON||NL (DEN HAAG)||participant||645˙129.00|
|4||DEUTSCHE FORSCHUNGSGEMEINSCHAFT||DE (BONN)||participant||384˙635.00|
|5||MINISTERO DELLA SALUTE||IT (ROMA)||participant||384˙635.00|
|6||TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU||TR (ANKARA)||participant||384˙635.00|
|7||FONDS ZUR FÖRDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG||AT (WIEN)||participant||303˙231.00|
|8||REGIONE EMILIA ROMAGNA||IT (BOLOGNA)||participant||303˙231.00|
|9||INSTITUTO DE SALUD CARLOS III||ES (MADRID)||participant||221˙827.00|
|10||NARODOWE CENTRUM BADAN I ROZWOJU||PL (WARSZAWA)||participant||221˙827.00|
|11||Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii||RO (Bucharest)||participant||221˙827.00|
|12||FUNDACAO PARA A CIENCIA E A TECNOLOGIA||PT (LISBOA)||participant||164˙844.00|
|13||GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS||EL (ATHENS)||participant||150˙597.00|
|14||FEDERAAL FONDS VOOR WETENSCHAPPELIJK ONDERZOEK||BE (BRUXELLES)||participant||137˙166.00|
|15||MINISTRY OF HEALTH||IL (JERUSALEM)||participant||137˙166.00|
|16||VALSTS IZGLITIBAS ATTISTIBAS AGENTURA||LV (RIGA)||participant||127˙398.00|
|17||FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN||BE (BRUSSEL)||participant||124˙142.00|
|18||NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL||HU (BUDAPEST)||participant||107˙861.00|
|19||DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV||DE (KOELN)||participant||59˙018.00|
|20||ISTITUTO SUPERIORE DI SANITA||IT (ROMA)||participant||59˙018.00|
|21||CANADIAN INSTITUTES OF HEALTH RESEARCH||CA (OTTAWA ONTARIO)||participant||0.00|
|22||FONDS DE RECHERCHE DU QUEBEC - SANTE||CA (MONTREAL QUEBEC)||participant||0.00|
|23||GENOME CANADA||CA (OTTAWA)||participant||0.00|
|24||LATVIJAS ZINATNU AKADEMIJA||LV (RIGA)||participant||0.00|
|25||ORSZAGOS TUDOMANYOS KUTATASI ALAPPROGRAMOK IRODA||HU (BUDAPEST)||participant||0.00|
|26||OSTERREICHISCHE FORSCHUNGSFORDERUNGSGESELLSCHAFT MBH||AT (WIEN)||participant||0.00|
|27||SCHWEIZERISCHER NATIONALFONDS ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG||CH (Bern)||participant||0.00|
Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to care. That is why rare diseases are a prime example of a research area that strongly profits from coordination on a European scale. At present only few European countries fund research on rare diseases through specific dedicated programmes. Therefore, the funding of transnational collaborative research is the most effective joint activity to enhance the cooperation between scientists working on rare diseases in Europe and beyond. The E-Rare consortium was built to link responsible funding bodies that combine the scarce resources and fund rare disease research via Joint Transnational Calls (JTCs). The current E-Rare-3 project proposal will extend and strengthen the transnational cooperation by building on the experience and results of the previous E-Rare-1&2 programmes. The consortium comprises 26 institutions from 17 European, Associated and non-European countries. Its international dimension will be directly translated into close collaboration with IRDiRC and other relevant European and international initiatives. IRDiRC guidelines and policies will be implemented in the four JTCs and representatives of the IRDiRC Scientific Committees will be invited to join the Advisory Board of E-Rare-3. Members of the EUCERD group will be involved in identifying rare disease research needs. Patients’ organizations from Europe (represented by EURORDIS) and beyond will be invited as a key partner towards collaborative efforts for research promotion and funding. The collaboration with European Research Infrastructures will be consolidated to enhance efficient and participative research.
|Information on projects selected for funding including data on each participant and abstracts of the project proposals||Documents, reports||2020-02-26 15:11:07|
Take a look to the deliverables list in detail: detailed list of E-Rare-3 deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "E-RARE-3" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "E-RARE-3" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More
Integrating and decentralising diabetes and hypertension services in AfricaRead More